Literature DB >> 18341286

A potential route to neuroprostanes and isoprostanes: preparation of the four enantiomerically pure diastereomers of 13-F4t-neuroP.

Douglass F Taber1, P Ganapati Reddy, Kyle O Arneson.   

Abstract

We report a potential synthetic route to the isoprostanes and the neuroprostanes that could allow ready access to each of the enantiomerically pure diastereomers of the several regioisomers of these important human metabolites. The key transformation in the synthesis is a highly diastereoselective thermal intramolecular ene reaction. A critical observation is that the four enantiomerically pure diastereomers of an intermediate acetylenic ester are easily separated from one another. Each of these four has been carried on to a different enantiomerically pure diastereomer of 13-F4t-neuroprostane.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18341286     DOI: 10.1021/jo702600v

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  4 in total

1.  Preparation of the Major Urinary Metabolite of (-)-Prostaglandin E(2).

Authors:  Douglass F Taber; Peiming Gu
Journal:  Tetrahedron       Date:  2009-08-01       Impact factor: 2.457

2.  Asymmetric, organocatalytic, three-step synthesis of gamma-hydroxy-(E)-alpha,beta-unsaturated sulfones and esters.

Authors:  Kimberly S Petersen; Gary H Posner
Journal:  Org Lett       Date:  2008-09-24       Impact factor: 6.005

Review 3.  Assessment of Isoprostanes in Human Plasma: Technical Considerations and the Use of Mass Spectrometry.

Authors:  Yiu Yiu Lee; Jean-Marie Galano; Camille Oger; Claire Vigor; Reversat Guillaume; Jérôme Roy; Jean-Yves Le Guennec; Thierry Durand; Jetty Chung-Yung Lee
Journal:  Lipids       Date:  2016-09-26       Impact factor: 1.880

Review 4.  Isoprostanes and 4-hydroxy-2-nonenal: markers or mediators of disease? Focus on Rett syndrome as a model of autism spectrum disorder.

Authors:  Cinzia Signorini; Claudio De Felice; Thierry Durand; Camille Oger; Jean-Marie Galano; Silvia Leoncini; Alessandra Pecorelli; Giuseppe Valacchi; Lucia Ciccoli; Joussef Hayek
Journal:  Oxid Med Cell Longev       Date:  2013-06-13       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.